Hib/MenC risk groups: patient group direction (PGD) template

PGD template to support the provision of Hib/MenC vaccine to individuals with underlying medical conditions.


Hib/MenC risk groups: patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This patient group direction (PGD) template supports the provision of additional Haemophilus influenzae type b and meningococcal C conjugate vaccine doses to individuals with underlying medical conditions from 2 years of age.

It is valid from 1 November 2018 to 31 October 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 7 November 2016
Last updated 11 October 2018 + show all updates
  1. Added routine update.
  2. First published.